The Oxford-based medical technology company secured backing from Lauxera Capital Partners to expand its US footprint and advance research pipelines.
OrganOx
OrganOx builds automated perfusion devices to preserve donor livers for transplantation.
OrganOx is a medical technology company that develops automated normothermic machine perfusion devices for liver transplantation. Its flagship product, metra, preserves donor livers and allows surgeons to assess function prior to transplant.
Categories
Team

Craig Marshall
Chief Executive Officer
Craig brings operational experience from executive roles at OrganOx and Siemens Magnet Technology. He currently serves as a venture partner at Amadeus Capital Partners alongside non-executive directorships.
LinkedInOern Stuge
Executive Chairman
Oern brings life sciences and investment experience from board and advisory roles at Orsco Life Sciences, Intuitive Ventures, and Carthera. He previously served as executive chairman at OrganOx.
LinkedInInvestors
- £25.0M
- £4.6MBGFLead

Funding history
The investment from BGF will support the rollout of the metra liver preservation system in the United States.